High circulating levels of sICAM-1 and sVCAM-1 in the patients with Hashimoto’s thyroiditis

References

• Jublanc C, Beaudeux JL, Aubart F, Raphael M, Chadarevian R, Chapman MJ, Bonnefont-Rousselot D, Bruckert E. Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation. Nutr Metab Cardiovasc Dis. 2011;21:817–822.
   PubMed Web of Science ®Google Scholar
• Fowler PD, Tacker M, Whitley GS, Meager A, Nussey SS, Johnstone AP. Expression of intercellular adhesion molecule-1 (ICAM-1) on human thyroid cells lines correlated with their binding of lymphoblasts. Mol Cell Endocrinol. 1990;71:55–61.
   PubMed Web of Science ®Google Scholar
• Martin A, Huber GK, Davies TF. Induction of human thyroid cell ICAM-1 (CD54) antigen expression and ICAM-1-mediated lymphocyte binding. Endocrinology. 1990;127:651–657.
   PubMed Web of Science ®Google Scholar
• Miyazaki A, Mirakian R, Bottazzo GF. Adhesion molecule expression in Graves’ thyroid glands; potential relevance of granule membrane protein (GMP-140) and intercellular adhesion molecule-1 (ICAM-1) in the homing and antigen presentation processes. Clin Exp Immunol. 1992;89:52–57.
   PubMed Web of Science ®Google Scholar
• Heufelder AE, Bahn RS. Graves’ immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves’ orbital fibroblasts. Eur J Clin Invest.1992;22:529–537.
   Google Scholar
• De Bellis A, Bizzarro A, Gattoni A, Romano C, Di Martino S, Sinisi AA, Abbadessa S, Bellastella A. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves’ disease with or without ophthalmopathy and in patients with toxic adenoma. J Clin Endocrinol Metab. 1995;80:2118–2121.
   PubMed Web of Science ®Google Scholar
• Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med. 1999;107:85–97.
   PubMed Web of Science ®Google Scholar
• Marazuela M, Postigo AA, Acevedo A, Diaz-Gonzalez F, Sanchez-Madrid F, de Landazuri MO. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves’ and Hashimoto’s thyroid glands. Eur J Immunol. 1994;24:2483–2490.
   PubMed Web of Science ®Google Scholar
• Pesce G, Fiorino N, Riccio AM, Montagna P, Torre G, Salmaso C, Altrinetti V, Bagnasco M. Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto’s thyroiditis and Graves’ disease: analysis at mRNA level and association with B7.1 costimulatory molecule. J Endocrinol Invest. 2002;25:289–295.
   PubMed Web of Science ®Google Scholar
• Heufelder AE, Bahn RS. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves’ ophthalmopathy. Clin Exp Immunol. 1993;91:381–389.
   PubMed Web of Science ®Google Scholar
• Sonnet E, Massart C, Gibassier J, Allannic H, Maugendre D. Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves’ disease. J Endocrinol Invest. 1999;22:430–435.
   PubMed Web of Science ®Google Scholar
• Ozata M, Bolu E, Sengul A, Altinsoy HI, Turan M, Corakci A, Hacibektasoglu A, Gundogan MA. Soluble intercellular adhesion molecule-1 concentrations in patients with subacute thyroiditis and in patients with Graves’ disease with or without ophthalmopathy. Endocr J. 1996;43:517–525.
   PubMed Web of Science ®Google Scholar
• Poplawska-Kita A, Szelachowska M, Modzelewska A, Siewko K, Dzieciol J, Klimiuk PA, Gorska M. Endothelial dysfunction in Graves’ disease. Adv Med Sci. 2013;58:31–37.
   PubMed Web of Science ®Google Scholar
• Lampeter ER, Kishimoto TK, Rothlein R, Mainolfi EA, Bertrams J, Kolb H, Martin S. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes. 1992;41:1668–1671.
   PubMed Web of Science ®Google Scholar
• Chen NG, Holmes M, Reaven GM. Relationship between insulin resistance, soluble adhesion molecules, and mononuclear cell binding in healthy volunteers. J Clin Endocrinol Metab. 1999;84:3485–3489.
   PubMed Web of Science ®Google Scholar
• Hak AE, Pols HA, Stehouwer CD, Meijer J, Kiliaan AJ, Hofman A, Breteler MM, Witteman JC. Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab. 2001;86:4398–4405.
   PubMed Web of Science ®Google Scholar
• Ito H, Ohshima A, Inoue M, Ohto N, Nakasuga K, Kaji Y, Maruyama T, Nishioka K. Weight reduction decreases soluble cellular adhesion molecules in obese women. Clin Exp Pharmacol Physiol. 2002;29:399–404.
   PubMed Web of Science ®Google Scholar
• Straczkowski M, Lewczuk P, Dzienis-Straczkowska S, Kowalska I, Stepien A, Kinalska I. Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity. Metabolism. 2002;51:75–78.
   PubMed Web of Science ®Google Scholar
• Topaloglu O, Gokay F, Kucukler K, Burnik FS, Mete T, Yavuz HC, Berker D, Guler S. Is autoimmune thyroiditis a risk factor for early atherosclerosis in premenopausal women even if in euthyroid status? Endocrine. 2013;44:145–151.
   PubMed Web of Science ®Google Scholar
• Heufelder AE, Bahn RS. Soluble intercellular adhesion molecule-1 (sICAM-1) in sera of patients with Graves’ ophthalmopathy and thyroid diseases. Clin Exp Immunol. 1993;92:296–302.
   PubMed Web of Science ®Google Scholar
• Fukazawa H, Yoshida K, Kaise N, Kiso Y, Sayama N, Mori K, Kikuchi K, Aizawa Y, Rikimaru A, Abe K. Intercellular adhesion molecule-1 (ICAM-1) in the sera of patients with Graves’ disease: correlation with disease activity and treatment status. Thyroid. 1995;5:373–377.
   PubMed Web of Science ®Google Scholar
• Lu M, Fang P, Zhang Z, He H, Gao S, Hou B, Zheng R, Xiao Q, Yang L. A preliminary clinical application of sICAM-1 RIA in three kinds of thyroid disease. Chin Med J (Engl). 2002;115:1552–1555.
   PubMed Web of Science ®Google Scholar
• Wenisch C, Myskiw D, Gessl A, Graninger W. Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism. J Clin Endocrinol Metab. 1995;80:2122–2126.
   PubMed Web of Science ®Google Scholar
• Ozata M, Bolu E, Sengul A, Tasar M, Beyhan Z, Corakci A, Gundogan MA. Effects of octreotide treatment on Graves’ ophthalmopathy and circulating sICAM-1 levels. Thyroid. 1996;6:283–288.
   PubMed Web of Science ®Google Scholar
• Pappa A, Calder V, Fells P, Lightman S. Adhesion molecule expression in vivo on extraocular muscles (EOM) in thyroid-associated ophthalmopathy (TAO). Clin Exp Immunol. 1997;108:309–313.
   PubMed Web of Science ®Google Scholar
• Nakashima M, Eguchi K, Ida H, Yamashita I, Sakai M, Origuchi T, Kawabe Y, Ishikawa N, Ito K, Nagataki S. The expression of adhesion molecules in thyroid glands from patients with Graves’ disease. Thyroid. 1994;4:19–25.
   PubMed Web of Science ®Google Scholar
• Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am. 2001;30:315–337.
   PubMed Web of Science ®Google Scholar
• Strieder TG, Prummel MF, Tijssen JG, Endert E, Wiersinga WM. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf). 2003;59:396–401.
   PubMed Web of Science ®Google Scholar
• Iddah MA, Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinol. 2013;26:2013:509764.
   Google Scholar
• Damle NK, Aruffo A. Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes. Proc Natl Acad Sci USA. 1991;88:6403–6407.
   PubMed Web of Science ®Google Scholar
• Marlin SD, Staunton DE, Springer TA, Stratowa C, Sommergruber W, Merluzzi VJ. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature. 1990;344:70–72.
   PubMed Web of Science ®Google Scholar
• DeSouza CA, Dengel DR, Macko RF, Cox K, Seals DR. Elevated levels of circulating cell adhesion molecules in uncomplicated essential hypertension. Am J Hypertens. 1997;10:1335–1341.
   PubMed Web of Science ®Google Scholar
• Hackman A, Abe Y, Insull W, Jr., Pownall H, Smith L, Dunn K, Gotto AM, Jr., Ballantyne CM. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation 1996;93:1334–1338.
   PubMed Web of Science ®Google Scholar
• Koga M, Otsuki M, Kubo M, Hashimoto J, Kasayama S. Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabet Med. 1998;15:661–667.
   PubMed Web of Science ®Google Scholar
• Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes. 1997;46 Suppl 2:S9–S13.
   PubMed Web of Science ®Google Scholar
• Taki H, Kashiwagi A, Tanaka Y, Horiike K. Expression of intercellular adhesion molecules 1 (ICAM-1) via an osmotic effect in human umbilical vein endothelial cells exposed to high glucose medium. Life Sci. 1996;58:1713–1721.
   PubMed Web of Science ®Google Scholar